Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.022 | 0.7 |